RNASE1 and cancer: We also succeeded in the release rate of RNase A, a protein-based drug candidate for cancer therapy68, could be enhanced in response to the presence of anti-DNP IgG or avidin (Fig. 5e, Supplementary Figs. 36, 37, 38).